Product Overview

The Foster Nexthaler 200mcg 6mcg Inhalation Powder is a medication used to treat asthma in patients who require a combination of two medications to control their symptoms. This inhaler is specifically designed to deliver a precise dose of Beclometasone Dipropionate and Formoterol directly to the lungs, providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Key Benefits

• Combines two medications in one inhaler for convenience and effectiveness
• Helps to prevent asthma symptoms and flare-ups
• Provides both immediate and long-lasting relief
• Easy-to-use inhaler with a dose counter for accurate dosing
• Portable and discreet for use on-the-go

How It Works

The Beclometasone Dipropionate in the Foster Nexthaler helps to reduce inflammation in the airways, while the Formoterol works as a long-acting bronchodilator to help open up the airways and make breathing easier. By delivering these medications directly to the lungs, the Nexthaler provides targeted relief and helps to improve lung function over time.

Directions for Use

1. Remove the cap and hold the inhaler upright.
2. Twist the base in the direction of the arrows until it clicks.
3. Breathe out gently, then place the mouthpiece between your lips and close them around it.
4. Inhale deeply and slowly through the mouthpiece, then hold your breath for 10 seconds.
5. Breathe out slowly and replace the cap.

Precautions

• Do not exceed the recommended dose or frequency of use.
• Rinse your mouth with water after each use to prevent thrush.
• If you experience any side effects or worsening symptoms, consult your healthcare provider.

Storage Instructions

Store the Foster Nexthaler in a cool, dry place away from heat and direct sunlight. Keep out of reach of children and pets. Do not puncture or incinerate the inhaler.

Manufacturer Information

The Foster Nexthaler 200mcg 6mcg Inhalation Powder is manufactured by Chiesi, a reputable pharmaceutical company known for producing high-quality respiratory medications. Chiesi is committed to improving the lives of patients with respiratory conditions through innovative treatments and research.